Aspirin prophylaxis in people without prior cardiovascular disease does not lead to reductions in cardiovascular death or cancer mortality

Muhammad U. Farooq*, Philip B. Gorelick

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)e14
JournalEvidence-Based Medicine
Volume18
Issue number2
DOIs
StatePublished - Apr 2013

ASJC Scopus subject areas

  • General Medicine

Cite this